Cancer Diagnostics Market: By Product Type (Consumables Instruments, Imaging Devices), By Technology (In-Vitro Diagnostics Techniques, Molecular Diagnostics Techniques, Imaging Technique, and Biopsy Techniques), By Application (Breast Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Skin Cancer, Prostate Cancer, Others), By End User (Hospitals and Diagnostic Centers, Cancer Clinics, Academic and Research Institutes, Others), and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Cancer Diagnostics Market size was valued at USD 122.4 billion in 2022 and is anticipated to grow at a CAGR of 7.8 % over 2023-2029. The cancer diagnostics market is a rapidly growing and vital segment of the healthcare sector focused on cancer detection and diagnosis. Cancer diagnostics, which include a variety of diagnostic tests, imaging procedures, and laboratory analyses, play an important role in cancer detection, allowing healthcare providers to provide timely and effective treatment options, resulting in better patient outcomes and survival rates. The increased cancer prevalence is majorly driving the cancer diagnostics market. Cancer is one of the main causes of mortality globally, with millions of new cases diagnosed each year. According to the American Cancer Society 2022, approximately 1.9 million new cancer cases were diagnosed across the USA and more than 6 lakh deaths occurred with the disease. Moreover, advancements in early detection and diagnosis technologies have revolutionized cancer diagnostics, fueling the cancer diagnostics market's development. Furthermore, advancements in biomarker discovery and rising demand for liquid biopsy create significant opportunities for the growth and development of the cancer diagnostics market. On top of that some of the recent trends such as the incorporation of artificial intelligence (AI) and machine learning with diagnostic tools and point-of-care (POC) cancer diagnostics devices are shaping the cancer diagnostics market. However, the high costs of diagnostic tests, as well as stringent regulatory approval processes, act as restraints to the growth of the cancer diagnostics market. Major market players are focusing on the development of innovative solutions to provide better patient outcomes, early detection, and improved treatment strategies in the fight against cancer. For instance, in December 2022, Digistain launched a new revolutionary AI breast cancer diagnostic tool. 

The Cancer Diagnostics Market Key Developments:
  • In July 2023, CORE Diagnostics announced its collaboration with PredOmix Technologies to launch OncoVeryx-F, a multi-cancer detection test specifically designed for high-risk and asymptomatic women. This technology offers screening solutions for four cancers, including breast, endometrial, cervical, and ovarian cancer
  • In Jun-2022, Roche launched new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care.

Cancer Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.80%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Cancer Diagnostics Market Dynamics

The rising demand for Personalized Medicine is majorly driving the expansion of the cancer diagnostics market. Cancer diagnostics are critical components of personalized medicine techniques. Identifying precise genetic and molecular abnormalities in tumors helps doctors to personalize treatment approaches to each patient's cancer's unique features. Furthermore, rising public awareness of cancer and the need for early diagnosis has resulted in increasing screening rates and increased demand for cancer diagnostic tests. In addition, governments and healthcare organizations throughout the world are expanding their investments in cancer research and diagnostic programs. This financial assistance promotes the development and implementation of innovative cancer diagnostic technology.

Cancer Diagnostics Market Segmentation

By Product Type
  • Consumables
  • Tissue Processing Systems
  • Imaging Devices
By Technology
  • In-Vitro Diagnostics Techniques
  • Molecular Diagnostics Techniques
  • Imaging Technique
  • Biopsy Techniques
By Application
  • Breast Cancer
  • Lung Cancer
  • Kidney Cancer
  • Liver Cancer
  • Skin Cancer
  • Prostate Cancer
  • Others
By End User
  • Hospitals and Diagnostic Centers
  • Cancer Clinics
  • Academic and Research Institutes
  • Others

Frequently Asked Questions

The cancer diagnostics market was valued at USD 122.4 Million in 2022 and is expected to grow at 7.8 % CAGR over the forecast period 2023 – 2029.

Rising cancer prevalence, technological advancements in diagnostic tools, and rising demand for personalized medicine are some of the factors that create potential opportunities for the growth of the cancer diagnostics market.

The integration of AI and ML to the diagnostic tools, point-of-care cancer diagnostic tools are some of the major trends in the cancer diagnostics market.

Abbott, DiagnoCure Inc., Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Volpara Solutions Limited, Quest Diagnostics Incorporated., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Hologic, Inc., Astellas Pharma Inc., Merck KGaA, GE healthcare, CORE Diagnostics, Siemens Healthcare GmbH, Bristol-Myers Squibb Company, NeoGenomics Laboratories, Inc., Philips Healthcare, Digistain, BD, bioMérieux SA, GSK plc., Novartis AG, Lilly, Pfizer, Inc. are a few companies operating in cancer diagnostics market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Cancer Diagnostics Market Introduction 
2.1. Global Cancer Diagnostics Market  - Taxonomy
2.2. Global Cancer Diagnostics Market  - Definitions
2.2.1. Technology
2.2.2. Application
2.2.3. Product
2.2.4. End User
2.2.5. Region
3. Global Cancer Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
3.8. USP
3.9. Macro Trends
3.10. Epidemiology
3.11. PEST and PORTER Analysis
4. Global Cancer Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Cancer Diagnostics Market  By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. In-Vitro Diagnostics Techniques
5.1.1. Immunohistochemistry (IHC)
5.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.1.3. Market Opportunity Analysis 
5.1.2. Immunoassays
5.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.2.3. Market Opportunity Analysis 
5.1.3. Flow Cytometry
5.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3.3. Market Opportunity Analysis 
5.1.4. Others
5.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.4.3. Market Opportunity Analysis 
5.2. Molecular Diagnostics Techniques
5.2.1. PCR and Sanger dideoxy sequencing
5.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.1.3. Market Opportunity Analysis 
5.2.2. MLPA
5.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.2.3. Market Opportunity Analysis 
5.2.3. Next-generation Sequencing (NGS)
5.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3.3. Market Opportunity Analysis 
5.2.4. BEAMing
5.2.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.4.3. Market Opportunity Analysis 
5.2.5. Others
5.2.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.5.3. Market Opportunity Analysis 
5.3. Imaging technique
5.3.1. Magnetic Resonance Imaging (MRI)
5.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.1.3. Market Opportunity Analysis 
5.3.2. Computed Tomography (CT)
5.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
5.3.2.3. Market Opportunity Analysis 
5.3.3. Positron Emission Tomography (PET)
5.3.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
5.3.3.3. Market Opportunity Analysis 
5.3.4. Mammography
5.3.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
5.3.4.3. Market Opportunity Analysis 
5.3.5. Ultrasound
5.3.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
5.3.5.3. Market Opportunity Analysis 
5.4. Biopsy Techniques
5.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Cancer Diagnostics Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Breast Cancer
6.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Lung Cancer
6.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Kidney Cancer
6.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Liver Cancer
6.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Skin Cancer
6.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Prostate Canacer
6.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis 
7. Global Cancer Diagnostics Market  By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Consumables
7.1.1. Antibodies
7.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.1.3. Market Opportunity Analysis 
7.1.2. Kits & Reagents
7.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.2.3. Market Opportunity Analysis 
7.1.3. Probes
7.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3.3. Market Opportunity Analysis 
7.1.4. Other Consumables
7.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.4.3. Market Opportunity Analysis 
7.2. Instruments
7.2.1. Tissue Processing Systems
7.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.1.3. Market Opportunity Analysis 
7.2.2. Cell Processors
7.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.2.3. Market Opportunity Analysis 
7.2.3. PCR Instruments
7.2.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3.3. Market Opportunity Analysis 
7.2.4. NGS Instruments
7.2.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.4.3. Market Opportunity Analysis 
7.2.5. Others
7.2.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.5.3. Market Opportunity Analysis 
7.3. Imaging Devices
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Cancer Diagnostics Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Hospitals and Diagnostic Centers
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) 
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.1.3. Market Opportunity Analysis  
8.2. Cancer Clinics 
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) 
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.2.3. Market Opportunity Analysis  
8.3. Acadmic and Research institutes 
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) 
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.3.3. Market Opportunity Analysis  
8.4. Others 
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) 
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.4.3. Market Opportunity Analysis  
9.Global Cancer Diagnostics Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Latin America
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Middle East and Africa (MEA)
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6.  Global Cancer Diagnostics Market - Opportunity Analysis Index, By Application, Technology, Product, End User,  ,  ,  , and Region, 2023-2029
10. North America Cancer Diagnostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technology Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. In-Vitro Diagnostics Techniques
10.1.1.1. Immunohistochemistry (IHC) 
10.1.1.2. Immunoassays
10.1.1.3. Flow Cytometry
10.1.1.4. Others
10.1.2. Molecular Diagnostics Techniques
10.1.2.1. PCR and Sanger dideoxy sequencing
10.1.2.2. MLPA
10.1.2.3. Next-generation Sequencing (NGS)
10.1.2.4. BEAMing
10.1.2.5. Others
10.1.3. Imaging technique
10.1.3.1. Magnetic Resonance Imaging (MRI)
10.1.3.2. Computed Tomography (CT)
10.1.3.3. Positron Emission Tomography (PET)
10.1.3.4. Mammography
10.1.3.5. Ultrasound
10.1.4. Biopsy Techniques
10.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Breast Cancer
10.2.2. Lung Cancer
10.2.3. Kidney Cancer
10.2.4. Liver Cancer
10.2.5. Skin Cancer
10.2.6. Prostate Canacer
10.3. Product Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Consumables
10.3.1.1. Antibodies 
10.3.1.2. Kits & Reagents
10.3.1.3. Probes
10.3.1.4. Other Consumables
10.3.2. Instruments
10.3.2.1. Tissue Processing Systems
10.3.2.2. Cell Processors
10.3.2.3. PCR Instruments
10.3.2.4. NGS Instruments
10.3.2.5. Others
10.3.3. Imaging Devices
10.4. End User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1. Hospitals and Diagnostic Centers
10.4.2. Cancer Clinics
10.4.3. Acadmic and Research institutes
10.4.4. Others
10.5. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1. United States of America (USA)
10.5.2. Canada
11. Europe Cancer Diagnostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technology Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. In-Vitro Diagnostics Techniques
11.1.1.1. Immunohistochemistry (IHC) 
11.1.1.2. Immunoassays
11.1.1.3. Flow Cytometry
11.1.1.4. Others
11.1.2. Molecular Diagnostics Techniques
11.1.2.1. PCR and Sanger dideoxy sequencing
11.1.2.2. MLPA
11.1.2.3. Next-generation Sequencing (NGS)
11.1.2.4. BEAMing
11.1.2.5. Others
11.1.3. Imaging technique
11.1.3.1. Magnetic Resonance Imaging (MRI)
11.1.3.2. Computed Tomography (CT)
11.1.3.3. Positron Emission Tomography (PET)
11.1.3.4. Mammography
11.1.3.5. Ultrasound
11.1.4. Biopsy Techniques
11.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Breast Cancer
11.2.2. Lung Cancer
11.2.3. Kidney Cancer
11.2.4. Liver Cancer
11.2.5. Skin Cancer
11.2.6. Prostate Canacer
11.3. Product Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. Consumables
11.3.1.1. Antibodies 
11.3.1.2. Kits & Reagents
11.3.1.3. Probes
11.3.1.4. Other Consumables
11.3.2. Instruments
11.3.2.1. Tissue Processing Systems
11.3.2.2. Cell Processors
11.3.2.3. PCR Instruments
11.3.2.4. NGS Instruments
11.3.2.5. Others
11.3.3. Imaging Devices
11.4. End User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1. Hospitals and Diagnostic Centers
11.4.2. Cancer Clinics
11.4.3. Acadmic and Research institutes
11.4.4. Others
11.5. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1. Germany
11.5.2. France
11.5.3. Italy
11.5.4. United Kingdom (UK)
11.5.5. Spain
11.5.6. Rest of EU
12. Asia Pacific (APAC) Cancer Diagnostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technology Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. In-Vitro Diagnostics Techniques
12.1.1.1. Immunohistochemistry (IHC) 
12.1.1.2. Immunoassays
12.1.1.3. Flow Cytometry
12.1.1.4. Others
12.1.2. Molecular Diagnostics Techniques
12.1.2.1. PCR and Sanger dideoxy sequencing
12.1.2.2. MLPA
12.1.2.3. Next-generation Sequencing (NGS)
12.1.2.4. BEAMing
12.1.2.5. Others
12.1.3. Imaging technique
12.1.3.1. Magnetic Resonance Imaging (MRI)
12.1.3.2. Computed Tomography (CT)
12.1.3.3. Positron Emission Tomography (PET)
12.1.3.4. Mammography
12.1.3.5. Ultrasound
12.1.4. Biopsy Techniques
12.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1. Breast Cancer
12.2.2. Lung Cancer
12.2.3. Kidney Cancer
12.2.4. Liver Cancer
12.2.5. Skin Cancer
12.2.6. Prostate Canacer
12.3. Product Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1. Consumables
12.3.1.1. Antibodies 
12.3.1.2. Kits & Reagents
12.3.1.3. Probes
12.3.1.4. Other Consumables
12.3.2. Instruments
12.3.2.1. Tissue Processing Systems
12.3.2.2. Cell Processors
12.3.2.3. PCR Instruments
12.3.2.4. NGS Instruments
12.3.2.5. Others
12.3.3. Imaging Devices
12.4. End User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1. Hospitals and Diagnostic Centers
12.4.2. Cancer Clinics
12.4.3. Acadmic and Research institutes
12.4.4. Others
12.5. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1. China
12.5.2. India
12.5.3. Australia and New Zealand (ANZ)
12.5.4. Japan
12.5.5. Rest of APAC
13. Latin America Cancer Diagnostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Technology Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1. In-Vitro Diagnostics Techniques
13.1.1.1. Immunohistochemistry (IHC) 
13.1.1.2. Immunoassays
13.1.1.3. Flow Cytometry
13.1.1.4. Others
13.1.2. Molecular Diagnostics Techniques
13.1.2.1. PCR and Sanger dideoxy sequencing
13.1.2.2. MLPA
13.1.2.3. Next-generation Sequencing (NGS)
13.1.2.4. BEAMing
13.1.2.5. Others
13.1.3. Imaging technique
13.1.3.1. Magnetic Resonance Imaging (MRI)
13.1.3.2. Computed Tomography (CT)
13.1.3.3. Positron Emission Tomography (PET)
13.1.3.4. Mammography
13.1.3.5. Ultrasound
13.1.4. Biopsy Techniques
13.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1. Breast Cancer
13.2.2. Lung Cancer
13.2.3. Kidney Cancer
13.2.4. Liver Cancer
13.2.5. Skin Cancer
13.2.6. Prostate Canacer
13.3. Product Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1. Consumables
13.3.1.1. Antibodies 
13.3.1.2. Kits & Reagents
13.3.1.3. Probes
13.3.1.4. Other Consumables
13.3.2. Instruments
13.3.2.1. Tissue Processing Systems
13.3.2.2. Cell Processors
13.3.2.3. PCR Instruments
13.3.2.4. NGS Instruments
13.3.2.5. Others
13.3.3. Imaging Devices
13.4. End User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1. Hospitals and Diagnostic Centers
13.4.2. Cancer Clinics
13.4.3. Acadmic and Research institutes
13.4.4. Others
13.5. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of LA
14. Middle East and Africa (MEA) Cancer Diagnostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Technology Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1. In-Vitro Diagnostics Techniques
14.1.1.1. Immunohistochemistry (IHC) 
14.1.1.2. Immunoassays
14.1.1.3. Flow Cytometry
14.1.1.4. Others
14.1.2. Molecular Diagnostics Techniques
14.1.2.1. PCR and Sanger dideoxy sequencing
14.1.2.2. MLPA
14.1.2.3. Next-generation Sequencing (NGS)
14.1.2.4. BEAMing
14.1.2.5. Others
14.1.3. Imaging technique
14.1.3.1. Magnetic Resonance Imaging (MRI)
14.1.3.2. Computed Tomography (CT)
14.1.3.3. Positron Emission Tomography (PET)
14.1.3.4. Mammography
14.1.3.5. Ultrasound
14.1.4. Biopsy Techniques
14.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1. Breast Cancer
14.2.2. Lung Cancer
14.2.3. Kidney Cancer
14.2.4. Liver Cancer
14.2.5. Skin Cancer
14.2.6. Prostate Canacer
14.3. Product Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1. Consumables
14.3.1.1. Antibodies 
14.3.1.2. Kits & Reagents
14.3.1.3. Probes
14.3.1.4. Other Consumables
14.3.2. Instruments
14.3.2.1. Tissue Processing Systems
14.3.2.2. Cell Processors
14.3.2.3. PCR Instruments
14.3.2.4. NGS Instruments
14.3.2.5. Others
14.3.3. Imaging Devices
14.4. End User Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1. Hospitals and Diagnostic Centers
14.4.2. Cancer Clinics
14.4.3. Acadmic and Research institutes
14.4.4. Others
14.5. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
15.  Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. GE Healthcare
15.2.2. Hologic Inc.
15.2.3. F. Hoffmann-La Roche Ltd
15.2.4. bioMérieux SA
15.2.5. Siemens Healthcare GmbH
15.2.6. Thermo Fisher Scientific, Inc.
15.2.7. Hologic, Inc.
15.2.8. Agilent Technologies, Inc.
15.2.9. Illumina, Inc.
15.2.10. Becton, Dickinson and Company
15.2.11. QIAGEN N.V.
15.2.12. Abbott Laboratories, Inc.
15.2.13. Philips Healthcare
15.2.14. NeoGenomics Laboratories, Inc.
15.2.15. Volpara Solutions Limited
16.  Research Methodology
17.  Key Assumptions and Acronyms
  • Abbott Laboratories
  • Siemens Healthineers
  • Becton, Dickinson and Company
  • Illumina, Inc.
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Qiagen N.V.
  • ThermoFisher Scientific, Inc.
  • Quest Diagnostics
  • bioMérieux SA
  • MDNA Life Sciences, Inc.

Adjacent Markets